|
|
Profile
|
Delegates :
Satoru TANAKA |
|
Incorporated :
February 5 , 2004 |
Paid in Capital :
133 Million yen 2012 |
Employees :
28 人 |
Address :
NANOBIC #2007 7-7 Shinkawasaki, Saiwai-ku, Kawasaki KANAGAWA
〒212-0032
|
TEL/FAX :
+81-44-820-0551 / +81-44-820-0552 |
URL：
http://www.scivax.com/usa/index.html |
Attachment :
|
Mission/Background :
SCIVAX Corporation is a nanotechnology-based venture company and has been established at 2004. We are developing various biomimicking products by nanoimprint technology. Our microtiterplate for 3-dimensional cell culture, NanoCulture(R); Plate (NCP) is a powerful tool for innovative drug discovery. We supply total solution for 3D cell culture. |
|
Technology & Business
|
SCIVAX NanoCulture(R); Plate (NCP) is a novel technology for 3D cell culture that combines the advantages of scaffold-based technologies with the ease of use found in other platforms. A bio-mimetic “structure” pattern that mimics structures observed in normal extracellular matrix supports the development of spheroids in a consistent and reproducible manner. Cells can be propagated using normal tissue culture techniques and then seeded into NCP plates for spheroid development. Once seeded, plates are handled in a similar manner as for conventional cell culture including visualization, automated liquid handling and harvesting of cells for analysis. Scivax has demonstrated that over 100 cell types produce robust spheroids on NCP including primary tumor cells, tumor-derived cell lines, fibroblasts, adipocytes, osteoblasts, stem cells, hepatocytes making NCP technology a versatile .
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
NanoCulture(R); Plate
|
Approved
|
Microplate for 3D cell culture
|
Sales increases
|
Hypoxia probe LOX-1
|
Approved
|
Reagent for hypoxia detection inside cells
|
Sales increases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
SCIVAX is developing 384-well plate and 35 mm dish for 3D cell culture
These products are scheduled to go on sales.
|
|
Hot news
|
Upcoming products
・384-well plate for high-throughput cell based assay
・35 mm dish for protein/RNA extraction
|
|
Alliance strategy
|
SCIVAX is a leading company of 3D cell culture, and seeks an alliance partner regarding anti-cancer drug discoveries.
|
|
|